<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9396258</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">36016543</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9396258</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3389/fneur.2022.927481</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Demographic data of the participants.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T1"><label>Table 1</label><caption><p>Demographic data of the participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>Healthy controls</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Parkinson's disease</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>N</italic></td><td valign="top" align="center" rowspan="1" colspan="1">16</td><td valign="top" align="center" rowspan="1" colspan="1">15</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (mean +/- SD)</td><td valign="top" align="center" rowspan="1" colspan="1">64.63 +/- 8.84</td><td valign="top" align="center" rowspan="1" colspan="1">65.34 +/- 6.81</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sex (male/female)</td><td valign="top" align="center" rowspan="1" colspan="1">8/9</td><td valign="top" align="center" rowspan="1" colspan="1">11/4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">UPDRSIII-motor (mean +/- SD)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">25.00 +/- 9.82</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hoehn-Yahr stage (median, range)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">3 (1–4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Disease duration (years, mean +/- SD)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">8.13 +/- 5.82 (1–20)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Levodopa equivalent daily dose (LEDD; mean +/- SD, range)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">798.27 +/- 483.95 (0–1,800)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Dominant side of motor symptoms (R: right, L: left, B: both)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">7R,7L,1B</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic data of the participants.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top" align="center">Healthy controls</th><th valign="top" align="center">Parkinson's disease</th></tr></thead><tbody><tr><td valign="top" align="left">N</td><td valign="top" align="center">16</td><td valign="top" align="center">15</td></tr><tr><td valign="top" align="left">Age (mean +/- SD)</td><td valign="top" align="center">64.63 +/- 8.84</td><td valign="top" align="center">65.34 +/- 6.81</td></tr><tr><td valign="top" align="left">Sex (male/female)</td><td valign="top" align="center">8/9</td><td valign="top" align="center">11/4</td></tr><tr><td valign="top" align="left">UPDRSIII-motor (mean +/- SD)</td><td valign="top" align="center">-</td><td valign="top" align="center">25.00 +/- 9.82</td></tr><tr><td valign="top" align="left">Hoehn-Yahr stage (median, range)</td><td valign="top" align="center">-</td><td valign="top" align="center">3 (1–4)</td></tr><tr><td valign="top" align="left">Disease duration (years, mean +/- SD)</td><td valign="top" align="center">-</td><td valign="top" align="center">8.13 +/- 5.82 (1–20)</td></tr><tr><td valign="top" align="left">Levodopa equivalent daily dose (LEDD; mean +/- SD, range)</td><td valign="top" align="center">-</td><td valign="top" align="center">798.27 +/- 483.95 (0–1,800)</td></tr><tr><td valign="top" align="left">Dominant side of motor symptoms (R: right, L: left, B: both)</td><td valign="top" align="center">-</td><td valign="top" align="center">7R,7L,1B</td></tr></tbody></table></div></transformed-table></extracted-table></extracted-tables-set>